https://www.selleckchem.com/products/xct-790.html
Use of Actin FSL activated partial thromboplastin time (APTT) reagent in the central laboratory resulted in lower FIXC values compared with other APTT reagents tested. The chromogenic assay determined lower FIXC than any of the one-stage assays. The rHFIX-Padua protein-spiked samples showed similar results. In contrast, FIXC results for rHFIX-nonacog alfa measured within 25% of expected for all one-stage assays and below 25% in the chromogenic assay. Assay-based differences in FIXC were observed for fidanacogene elaparvovec transgene pr